Quick Answer
Nuvation Bio Inc. reported Operating Income of -$213.06 million for fiscal year 2025.
Nuvation Bio Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$213.06M | +64.0% |
| 2024 | -$592.63M | -493.7% |
| 2023 | -$99.82M | +16.6% |
| 2022 | -$119.73M | -28.3% |
| 2021 | -$93.32M | -114.3% |
| 2020 | -$43.55M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$56.43M | -17.3% | +11.3% |
| June 30, 2025 | -$63.59M | +86.5% | -7.8% |
| March 31, 2025 | -$59.00M | -192.1% | -22.7% |
| September 30, 2024 | -$48.10M | -82.6% | +89.8% |
| June 30, 2024 | -$470.38M | -1700.1% | -2228.8% |
| March 31, 2024 | -$20.20M | +23.8% | +23.3% |
| September 30, 2023 | -$26.34M | +10.2% | -0.8% |
| June 30, 2023 | -$26.13M | +31.0% | +1.5% |
- Nuvation Bio Inc. showed an increase of +64.0% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Nuvation Bio Inc.’s operating income has declined by 389.2% (from -$43.55 million to -$213.06 million).
- The most recent figure is from Nuvation Bio Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: